{
  "symbol": "GE",
  "year": 2022,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": -0.3182,
    "outlook_sentiment": 0.2597,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.072
  },
  "top_positive": [
    {
      "sent": "EARNINGS PER SHARE INFORMATION Three months ended September 30 2022 2021 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ ( 80 ) $ ( 80 ) $ 654 $ 654 Preferred stock dividends ( 73 ) ( 73 ) ( 52 ) ( 52 ) Accretion of redeemable noncontrolling interests, net of tax \u2014 \u2014 ( 9 ) ( 9 ) Accretion of preferred share repurchase 3 3 \u2014 \u2014 Earnings (loss) from continuing operations attributable to common shareholders ( 150 ) ( 150 ) 593 593 Earnings (loss) from discontinued operations ( 85 ) ( 85 ) 602 602 Net earnings (loss) attributable to GE common shareholders ( 234 ) ( 234 ) 1,195 1,195 Shares of GE common stock outstanding 1,095 1,095 1,098 1,098 Employee compensation-related shares (including stock options) \u2014 \u2014 7 \u2014 Total average equivalent shares 1,095 1,095 1,105 1,098 Earnings (loss) per share from continuing operations $ ( 0.14 ) $ ( 0.14 ) $ 0.54 $ 0.54 Earnings (loss) per share from discontinued operations ( 0.08 ) ( 0.08 ) 0.54 0.55 Net earnings (loss) per share ( 0.21 ) ( 0.21 ) 1.08 1.09 Potentially dilutive securities(a) 49 37 Nine months ended September 30 2022 2021 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ ( 1,417 ) $ ( 1,417 ) $ 179 $ 179 Preferred stock dividends ( 192 ) ( 192 ) ( 180 ) ( 180 ) Accretion of redeemable noncontrolling interests, net of tax \u2014 \u2014 ( 9 ) ( 9 ) Accretion of preferred share repurchase 3 3 \u2014 \u2014 Earnings (loss) from continuing operations attributable to common shareholders ( 1,606 ) ( 1,606 ) ( 11 ) ( 11 ) Earnings (loss) from discontinued operations ( 580 ) ( 580 ) ( 2,856 ) ( 2,856 ) Net earnings (loss) attributable to GE common shareholders ( 2,186 ) ( 2,186 ) ( 2,866 ) ( 2,866 ) Shares of GE common stock outstanding 1,097 1,097 1,097 1,097 Employee compensation-related shares (including stock options) \u2014 \u2014 \u2014 \u2014 Total average equivalent shares 1,097 1,097 1,097 1,097 Earnings (loss) from continuing operations $ ( 1.46 ) $ ( 1.46 ) $ ( 0.01 ) $ ( 0.01 ) Earnings (loss) from discontinued operations ( 0.53 ) ( 0.53 ) ( 2.60 ) ( 2.60 ) Net earnings (loss) per share ( 1.99 ) ( 1.99 ) ( 2.61 ) ( 2.61 ) Potentially dilutive securities(a) 46 42 (a) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.",
      "score": 0.9932
    },
    {
      "sent": "2022 3Q FORM 10-Q 16 2021 assumption 2022 assumption Hypothetical change in 2022 assumption Estimated adverse impact to projected present value of future cash flows (In millions, pre-tax) Long-term care insurance morbidity improvement 1.25% per year over 12 to 20 years 1.25% per year over 12 to 20 years 25 basis point reduction No morbidity improvement $500 $2,500 Long-term care insurance morbidity Based on company experience Based on company experience 5% increase in dollar amount of paid claims $900 Long-term care insurance mortality improvement 0.5% per year for 10 years with annual improvement graded to 0% over next 10 years 0.5% per year for 10 years with annual improvement graded to 0% over next 10 years 1.0% per year for 10 years with annual improvement graded to 0% over next 10 years $400 Total terminations: Long-term care insurance mortality Based on company experience Based on company experience Any change in termination assumptions that reduce total terminations by 10% $900 Long-term care insurance lapse rate Varies by block, attained age and benefit period; average 0.5% - 1.15% Varies by block, attained age and benefit period; average 0.5% -1.15% Long-term care insurance benefit exhaustion Based on company experience Based on company experience Long-term care insurance future premium rate increases Varies by block based on filing experience Varies by block based on filing experience 25% adverse change in success rate on premium rate increase actions not yet approved $200 Overall discount rate 6.15% 6.20% 25 basis point reduction $700 Life insurance mortality Based on company experience Based on company experience 5% increase in mortality $300 While higher assumed inflation, holding all other assumptions constant, would result in unfavorable impacts to the projected present value of future cash flows, it would be expected to be mitigated by a higher discount rate and contractual daily or monthly benefit caps.",
      "score": 0.9919
    },
    {
      "sent": "2022 3Q FORM 10-Q 16 2021 assumption 2022 assumption Hypothetical change in 2022 assumption Estimated adverse impact to projected present value of future cash flows (In millions, pre-tax) Long-term care insurance morbidity improvement 1.25% per year over 12 to 20 years 1.25% per year over 12 to 20 years 25 basis point reduction No morbidity improvement $500 $2,500 Long-term care insurance morbidity Based on company experience Based on company experience 5% increase in dollar amount of paid claims $900 Long-term care insurance mortality improvement 0.5% per year for 10 years with annual improvement graded to 0% over next 10 years 0.5% per year for 10 years with annual improvement graded to 0% over next 10 years 1.0% per year for 10 years with annual improvement graded to 0% over next 10 years $400 Total terminations: Long-term care insurance mortality Based on company experience Based on company experience Any change in termination assumptions that reduce total terminations by 10% $900 Long-term care insurance lapse rate Varies by block, attained age and benefit period; average 0.5% - 1.15% Varies by block, attained age and benefit period; average 0.5% -1.15% Long-term care insurance benefit exhaustion Based on company experience Based on company experience Long-term care insurance future premium rate increases Varies by block based on filing experience Varies by block based on filing experience 25% adverse change in success rate on premium rate increase actions not yet approved $200 Overall discount rate 6.15% 6.20% 25 basis point reduction $700 Life insurance mortality Based on company experience Based on company experience 5% increase in mortality $300 While higher assumed inflation, holding all other assumptions constant, would result in unfavorable impacts to the projected present value of future cash flows, it would be expected to be mitigated by a higher discount rate and contractual daily or monthly benefit caps.",
      "score": 0.9919
    }
  ],
  "top_negative": [
    {
      "sent": "These decreases were partially offset by $0.2 billion of lower losses on purchases and sales of business interests due to a $0.2 billion held for sale loss within our Power segment in 2021 and $0.1 billion of lower restructuring and other charges.",
      "score": -0.8176
    },
    {
      "sent": "The rate was negative primarily due to the net unrealized capital loss on our interest in AerCap and Baker Hughes for which the loss could not be tax benefited, losses in foreign jurisdictions where they are not likely to be utilized, non-tax benefited asset impairment charges and the global intangible minimum tax provisions partially offset by U.S.",
      "score": -0.765
    },
    {
      "sent": "The rate was negative primarily due to the net unrealized capital loss on our interest in AerCap and Baker Hughes for which the loss could not be tax benefited, losses in foreign jurisdictions where they are not likely to be utilized, non-tax benefited asset impairment charges and the global intangible minimum tax provisions partially offset by U.S.",
      "score": -0.765
    }
  ],
  "forward_snippets": [
    "(AerCap) and our expected equity interest in GE HealthCare after its spin-off, the timing for such transactions, the ability to satisfy any applicable pre-conditions, and the expected proceeds, consideration and benefits to GE; \u2022 changes in macroeconomic and market conditions and market volatility, including impacts related to the COVID-19 pandemic, risk of recession, inflation, supply chain constraints or disruptions, rising interest rates, the value of securities and other financial assets (including our equity interests in Baker Hughes and AerCap, and our expected equity interest in GE HealthCare after its spin-off), oil, natural gas and other commodity prices and exchange rates, and the impact of such changes and volatility on our business operations, financial results and financial position; \u2022 the continuing severity, magnitude and duration of the COVID-19 pandemic, including impacts of virus variants and resurgences, and of government, business and individual responses, such as continued or new government-imposed lockdowns and travel restrictions and aviation passenger confidence; \u2022 our capital allocation plans, including de-leveraging actions to reduce GE's indebtedness, the capital structures of the three public companies that we plan to form from our businesses with the planned spin-offs, the timing and amount of dividends, share repurchases, acquisitions, organic investments, and other priorities; \u2022 downgrades of our current short- and long-term credit ratings or ratings outlooks, or changes in rating application or methodology, and the related impact on our funding profile, costs, liquidity and competitive position; \u2022 the amount and timing of our cash flows and earnings, which may be impacted by macroeconomic, customer, supplier, competitive, contractual and other dynamics and conditions; \u2022 capital and liquidity needs associated with our financial services operations, including in connection with our run-off insurance operations and mortgage portfolio in Poland (Bank BPH), the amount and timing of any required capital contributions and any strategic actions that we may pursue; \u2022 global economic trends, competition and geopolitical risks, including impacts from the ongoing conflict between Russia and Ukraine and the related sanctions and other measures, decreases in the rates of investment or economic growth globally or in key markets we serve, or an escalation of sanctions, tariffs or other trade tensions between the U.S.",
    "(AerCap) and our expected equity interest in GE HealthCare after its spin-off, the timing for such transactions, the ability to satisfy any applicable pre-conditions, and the expected proceeds, consideration and benefits to GE; \u2022 changes in macroeconomic and market conditions and market volatility, including impacts related to the COVID-19 pandemic, risk of recession, inflation, supply chain constraints or disruptions, rising interest rates, the value of securities and other financial assets (including our equity interests in Baker Hughes and AerCap, and our expected equity interest in GE HealthCare after its spin-off), oil, natural gas and other commodity prices and exchange rates, and the impact of such changes and volatility on our business operations, financial results and financial position; \u2022 the continuing severity, magnitude and duration of the COVID-19 pandemic, including impacts of virus variants and resurgences, and of government, business and individual responses, such as continued or new government-imposed lockdowns and travel restrictions and aviation passenger confidence; \u2022 our capital allocation plans, including de-leveraging actions to reduce GE's indebtedness, the capital structures of the three public companies that we plan to form from our businesses with the planned spin-offs, the timing and amount of dividends, share repurchases, acquisitions, organic investments, and other priorities; \u2022 downgrades of our current short- and long-term credit ratings or ratings outlooks, or changes in rating application or methodology, and the related impact on our funding profile, costs, liquidity and competitive position; \u2022 the amount and timing of our cash flows and earnings, which may be impacted by macroeconomic, customer, supplier, competitive, contractual and other dynamics and conditions; \u2022 capital and liquidity needs associated with our financial services operations, including in connection with our run-off insurance operations and mortgage portfolio in Poland (Bank BPH), the amount and timing of any required capital contributions and any strategic actions that we may pursue; \u2022 global economic trends, competition and geopolitical risks, including impacts from the ongoing conflict between Russia and Ukraine and the related sanctions and other measures, decreases in the rates of investment or economic growth globally or in key markets we serve, or an escalation of sanctions, tariffs or other trade tensions between the U.S.",
    "Percentages presented in this report are calculated from the un\n of securities and other financial assets (including our equity interests in Baker Hughes and AerCap, and our expected equity interest in GE HealthCare after its spin-off), oil, natural gas and other commodity prices and exchange rates, and the impact of such changes and volatility on our business operations, financial results and financial position; \u2022 the continuing severity, magnitude and duration of the COVID-19 pandemic, including impacts of virus variants and resurgences, and of government, business and individual responses, such as continued or new government-imposed lockdowns and travel restrictions and aviation passenger confidence; \u2022 our capital allocation plans, including de-leveraging actions to reduce GE's indebtedness, the capital structures of the three public companies that we plan to form from our businesses with the planned spin-offs, the timing and amount of dividends, share repurchases, acquisitions, organic investments, and other priorities; \u2022 downgrades of our current short- and long-term credit ratings or ratings outlooks, or changes in rating application or methodology, and the related impact on our funding profile, costs, liquidity and competitive position; \u2022 the amount and timing of our cash flows and earnings, which may be impacted by macroeconomic, customer, supplier, competitive, contractual and other dynamics and conditions; \u2022 capital and liquidity needs associated with our financial services operations, including in connection with our run-off insurance operations and mortgage portfolio in Poland (Bank BPH), the amount and timing of any required capital contributions and any strategic actions that we may pursue; \u2022 global economic trends, competition and geopolitical risks, including impacts from the ongoing conflict between Russia and Ukraine and the related sanctions and other measures, decreases in the rates of investment or economic growth globally or in key markets we serve, or an escalation of sanctions, tariffs or other trade tensions between the U.S.",
    "*Non-GAAP Financial Measure 2022 3Q FORM 10-Q 5 We continue to experience inflation pressure in our supply chain, as well as delays in sourcing key materials needed for our products.",
    "We continue to partner with our airline and leasing customers and collaborate with our airframe partners on future production rates."
  ]
}